eurological rehabilitation outcome of the treatment of patients with COVID-19 disease
Recruiting
- Conditions
- G62.80G72.80
- Registration Number
- DRKS00022845
- Lead Sponsor
- eurologische Klinik/ Station I2, Klinikum der Universität München
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
• Age> = 18 years
• COVID-19 pathogen detection using PCR (not for control group)
• COVID-associated rehabilitation diagnosis (e.g. CIP / CIM, stroke, GBS, encephalopathy) For the non-COVID-19 CIP / CIM control group: Proven CIP / CIM as a qualifying NNFR diagnosis
• Treatment from 1.1.2017 (i.b. for retrospective CIP / CIM control group)
• Treatment in the NNFR for at least 48 hours
• For a prospective sub-project: Written consent to study participation after detailed information
Exclusion Criteria
• For the prospective sub-project: Refusal to participate in the study
• Pregnant or breastfeeding
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method